The Shotlee Journal
Browse Shotlee articles about Health & Wellness.
Showing 9 / 258 Health & Wellness articles
The surge in GLP-1 medications for weight loss has led to a concerning trend: many online pharmacies are prescribing these powerful drugs with minimal to no doctor consultation, putting patients at significant risk.
Curious about peptides and their role in weight loss, cholesterol management, and overall health? This article breaks down what peptides are, how they work, and what the science says about popular options like GLP-1 agonists.
The rise of GLP-1 medications has revolutionized weight management. This comprehensive guide delves into semaglutide, tirzepatide, and other peptide therapies, offering insights into their efficacy, potential side effects, and how to track your progress effectively.
GLP-1 medications have revolutionized weight loss, but are they also changing how we feel, think, and connect? This article delves into the emerging 'Ozempic Personality' and the science behind potential mood and behavioral shifts.
Millions are experiencing significant weight loss with GLP-1 medications. But what happens to your bones, joints, and muscles as the pounds drop? An orthopedic surgeon shares crucial insights.
For many older Americans, the high cost of GLP-1 weight loss medications has been a significant barrier. Now, a new Medicare trial offers a lifeline, potentially making these life-changing drugs accessible for just $50 a month. This article breaks down what you need to know about the Medicare GLP-1 Bridge program, including who qualifies, which medications are covered, and the program's future.
A closer look at the groundbreaking GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and their transformative effects on weight management and overall health.
Melanie Sivier shares her remarkable 9-stone weight loss journey, opting for a dedicated lifestyle change over medical interventions like gastric bands and newer GLP-1 agonists.
Foreign residents in Brazil face a growing grey market of unregulated injectable peptides. Here is what the health regulator Anvisa says about safety and legality.
